Evidence map›Paper›PMID 39373306›Full record

ArticleActa paediatrica (Oslo, Norway : 1992)2025

A retrospective evaluation of SwePEWS use in paediatric patients with COVID-19 and RSV infection.

Julia Stolpe, Albin Wimmerdahl, Antoine Honoré, Karin Pukk Härenstam, David Forsberg

Abstract read
In one paragraph

Article in Acta paediatrica (Oslo, Norway : 1992), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julia StolpeDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Albin WimmerdahlDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Antoine HonoréDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Karin Pukk HärenstamDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
David ForsbergDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-4719-2201

Funding

Karolinska Institutet 2022-02348Stiftlesen Barnforskningen.
6 · The paper itself

Abstract

aimAs early detection of deterioration is a challenge in children, the Swedish Paediatric Early Warning Score (SwePEWS) is used to systematically assess paediatric patients' clinical state. Here, we aimed to evaluate the use and predictive ability of SwePEWS.

methodsElectronic health records of paediatric patients admitted due to respiratory syncytial virus infection or COVID-19 were reviewed retrospectively. Registered vital signs were compared to the assigned SwePEWS score and monitored vital sign values to identify discrepancies. Additionally, SwePEWS's ability to predict transfer to the paediatric intensive care unit (PICU) was assessed.

resultsAmong 1374 SwePEWS assessments, one-third were either incomplete or contained errors. Incomplete SwePEWS assessments were more frequent during night-time. Single measurements of oxygen saturation presented lower values compared to average saturation from continuous monitoring. SwePEWS's ability to predict PICU transfer was low.

conclusionThere was a surprisingly high occurrence of underestimated SwePEWS scores. This study provides new insights into pitfalls when developing and implementing paediatric early warning scores for systematic re-evaluations in paediatric patients.

Indexed as

COVID-19Respiratory Syncytial Virus InfectionsAdolescentChildChild, PreschoolEarly Warning ScoreFemaleHumansInfantIntensive Care Units, PediatricMaleRetrospective StudiesSwedendeteriorationPEWSreevaluationvital signs

Identifiers

PMID39373306
PMCPMC11706740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.